1. OC-0103 SCALOP2:A multicenter randomized trial of RT dose escalation and nelfinavir in pancreatic cancer. (May 2022) Authors: Mukherjee, S.; Qi, C.; Shaw, R.; Bridgewater, J.; Radhakrishna, G.; Patel, N.; Tranter, B.; Parsons, P.; Falk, S.; Wasan, H.; Holyoake, D.; Roy, R.; Scott-Brown, M.; Hurt, C.; Sebag-Montefiore, D.; Maughan, T.; Hawkins, M.; Corrie, P. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0269 Standard vs dose escalated chemoradiotherapy in anal cancer: Phase II results of the PLATO-ACT5 RCT. (May 2022) Authors: Gilbert, A.; Webster, J.; Brown, S.; Copeland, J.; Ruddock, S.; Adams, R.; Harrison, M.; Muirhead, R.; Renehan, A.; Sebag-Montefiore, D.; Hawkins, M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1321 Prognostic factors for anal cancer treated with conformal radiotherapy – a systematic review. (May 2022) Authors: Theophanous, S.; Samuel, R.; Lilley, J.; Henry, A.; Sebag-Montefiore, D.; Gilbert, A.; Appelt, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal Cancer. Issue 5 (May 2022) Authors: Slevin, F.; Hanna, C.R.; Appelt, A.; Cunningham, C.; Marijnen, C.A.M.; Sebag-Montefiore, D.; Muirhead, R. Journal: Clinical oncology Issue: Volume 34:Issue 5(2022) Page Start: e210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗